Risk-associated and clinically informative biomarkers for cardiovascular risk stratification in metabolic dysfunction–Associated steatotic liver disease

MASLD is associated with an approximate twofold increased risk of cardiovascular events, but this association varies based on population and clinical context. A concise and pragmatic panel-FIB-4, FLI, blood pressure, and triglyceride-glucose index, with type IV collagen 7S where available (and NAFLD-LFS in selected settings)-may complement established ASCVD risk assessment and support earlier, risk-guided prevention in routine MASLD care.